FDA Approves Merck's Sylatron (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement
Links shared publicly online about this topic.
- 367total visits
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement
View full resource at drugs.com
Tags: Cancer, Skin Cancer, Melanoma, FDA, Merck & Co.
Most Recently Shared on April 13, 2011 at 11:43 pm By:
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for the Adjuvant Treatment of Melanoma - http://bit.ly/f4t9Dr
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement
drugs.com — “Sylatron (peginterferon alfa-2b) is used for the adjuvant treatment of melanoma. Includes Sylatron side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 14, 2011 at 12:11 am By:
Drugs and Devices OW OW Health
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma... http://bit.ly/fpTNTP #drug
GEN | Industry Updates: FDA Approves Merck's SYLATRON™ (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement
genengnews.com — “GEN | Industry Updates: FDA Approves Merck's SYLATRON™ (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement” View full resource at genengnews.com
Most Recently Shared on April 12, 2011 at 11:43 am By:
Dr. Anthony Blash Doctor, Pharmacist, and PharmD
FDA Approves Merck's SYLATRONâ„¢ (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment fo... http://bit.ly/gr7yUC (via @news360app)
Advertisement
